120 related articles for article (PubMed ID: 27866975)
41. [Progress of research on breast cancer stem cell markers].
Liu X; Li W; Fu L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
[No Abstract] [Full Text] [Related]
42. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
43. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.
Custódio M; Pelissari C; Santana T; Trierveiler M
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1877-1883. PubMed ID: 29779037
[TBL] [Abstract][Full Text] [Related]
44. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
45. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187
[TBL] [Abstract][Full Text] [Related]
46. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
47. JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.
Maia LL; Peterle GT; Dos Santos M; Trivilin LO; Mendes SO; de Oliveira MM; Dos Santos JG; Stur E; Agostini LP; Couto CVMDS; Dalbó J; de Assis ALEM; Archanjo AB; Mercante AMDC; Lopez RVM; Nunes FD; de Carvalho MB; Tajara EH; Louro ID; Álvares-da-Silva AM
PLoS One; 2018; 13(3):e0194884. PubMed ID: 29590186
[TBL] [Abstract][Full Text] [Related]
48. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas.
Stoll C; Baretton G; Soost F; Terpe HJ; Domide P; Löhrs U
Oral Oncol; 1999 Sep; 35(5):484-9. PubMed ID: 10694948
[TBL] [Abstract][Full Text] [Related]
49. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
[TBL] [Abstract][Full Text] [Related]
50. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
[TBL] [Abstract][Full Text] [Related]
51. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
52. The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry.
Garrel R; Dromard M; Costes V; Barbotte E; Comte F; Gardiner Q; Cartier C; Makeieff M; Crampette L; Guerrier B; Boulle N
Clin Cancer Res; 2006 Apr; 12(8):2498-505. PubMed ID: 16638858
[TBL] [Abstract][Full Text] [Related]
53. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
54. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
[TBL] [Abstract][Full Text] [Related]
55. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
56. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
57. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
[TBL] [Abstract][Full Text] [Related]
58. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization.
Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A
J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092
[TBL] [Abstract][Full Text] [Related]
59. MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.
Valverde LF; de Freitas RD; Pereira TA; de Resende MF; Agra IMG; Dos Santos JN; Dos Reis MG; Sales CBS; Gurgel Rocha CA
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):120-125. PubMed ID: 27258565
[TBL] [Abstract][Full Text] [Related]
60. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
Lacy PD; Spitznagel EL; Piccirillo JF
Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
